Nasal Drug Development

Product description

Our nasal drug development scientists provide method development and validation and testing services to help you optimise the performance of your nasal drug products in either aqueous, powder or propellant-driven forms. Conducted in Good Manufacturing Compliant (GMP) laboratories, our services can support you from early-phase formulation development, CMC support, clinical release testing, through to finished product release testing and EU import testing. Our expertise includes integrated formulation development and scale-up, device screening, accelerated stability studies, clinical supply manufacture and full CMC support. We routinely provide in-vitro bioequivalence studies (IV-BE) for generic products, including full GMP statistical analysis and dossier generation. Bringing quality and safety to life, we offer Total Quality Assurance expertise to help you to meet and exceed quality, safety and regulatory standards.
Read more


Categories BiopharmaceuticalsCMC; BiopharmaceuticalsLeachables/Extractables/Particulates; Pharmaceutical PackagingPrefillable Inhalers
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from United Kingdom

More products from Intertek Pharmaceutical Services

View all our products (81)

Products from other suppliers